Based on an international consensus, we have defined a minimum and extended data set for real world data collection in Alzheimer’s disease.

This vital piece of work creates a foundation for data harmonisation and future collaboration between national and international registries, including InRAD, enhancing the power of large data sets and validity of real-world studies.

Manuscript development is underway.